Executive Summary
The 11 filings from Dow 30 constituents reveal a bifurcated market: consumer staples and payments giants show steady but decelerating growth, while tech titans like Microsoft post explosive cloud-driven results. A dominant theme is margin pressure from rising costs (P&G, Microsoft Intelligent Cloud) and aggressive capital returns via buybacks and dividends (Visa, Coca-Cola), which are shrinking equity bases.
Insider selling is a notable red flag, with Coca-Cola and Honeywell executives cashing out significant positions, while Microsoft's massive $678B commercial backlog signals future revenue visibility. Johnson & Johnson's acquisition-led guidance cut introduces risk in the healthcare sector, while P&G's leadership transition is orderly but adds uncertainty. The overarching portfolio-level pattern is a trade-off between strong top-line growth and compressed margins, with capital allocation favoring shareholders over reinvestment.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 10-Q · 8-K · Form 4 · 10-K
Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from July 28, 2026.
Investment Signals (12)
- Microsoft ↓ (BULLISH)▲
Q4 FY26 revenue of $90.0B (+18% YoY) and Azure revenue surpassing $100B for the fiscal year, with commercial RPO surging 84% to $678B, indicating massive future revenue visibility
- Microsoft ↓ (BULLISH)▲
GAAP net income surged 31% YoY to $35.8B and diluted EPS grew 32% to $4.81, significantly outpacing revenue growth, demonstrating operating leverage
- Coca-Cola ↓ (BULLISH)▲
Q2 net operating revenues rose 6.7% to $13,380M and net income grew 16.1% to $4,425M, with operating cash flow swinging from a use of $1,391M to $7,543M YoY, a massive improvement in cash generation
- Coca-Cola ↓ (BULLISH)▲
Long-term debt decreased 12.1% to $37,001M from $42,119M, strengthening the balance sheet while total equity rose 11.8% to $38,315M
- Visa ↓ (BULLISH)▲
Q3 FY2026 net revenue grew 14.3% to $11,633M and operating income rose 11.3% to $6,877M, with litigation provisions dropping 59% to $253M, reducing a key risk
- Johnson & Johnson ↓ (BULLISH)▲
Maintained operational sales growth guidance of 6.5%-7.1% despite lowering EPS guidance, indicating strong underlying business momentum
- Procter & Gamble ↓ (BULLISH)▲
FY2026 net sales grew 3% to $87.0B and diluted EPS rose 2% to $6.62, with Beauty segment organic sales up 4% in Q4, showing resilience in core categories
- Coca-Cola ↓ (BEARISH)▲
Insider Pietracci Bruno sold $3.62M in stock after exercising options at lower prices, a classic profit-taking pattern that signals insider belief shares are fairly valued or overvalued
- Honeywell ↓ (BEARISH)▲
Pres/CEO Process Technologies West Kenneth J sold $1.75M in stock, reducing holdings significantly, a bearish signal from a key divisional leader
- Microsoft ↓ (BEARISH)▲
More Personal Computing segment revenue declined 4% YoY in Q4, with Windows OEM down 7% and Xbox content down 10%, indicating weakness in legacy businesses
- Procter & Gamble ↓ (BEARISH)▲
Q4 FY26 diluted EPS declined 15% to $1.26 and core EPS fell 3% to $1.43, with organic sales flat, and FY27 guidance faces an $0.56 per share headwind from costs and FX
- Alphabet ↓ (BEARISH)▲
VP and Chief Accounting Officer sold $150K in stock under a 10b5-1 plan, a small but notable insider sale from a senior finance executive
Risk Flags (9)
- Microsoft/Intelligent Cloud Margin Pressure↓ [HIGH RISK]▼
Cost of revenue for Intelligent Cloud grew 44% YoY, outpacing its 30% revenue growth, indicating significant margin compression in the key growth segment
- Procter & Gamble/Guidance Headwinds↓ [HIGH RISK]▼
FY27 core EPS growth guided at in-line to 3%, but faces an 8% drag from higher costs and unfavorable FX ($0.56 per share), implying underlying weakness
- Johnson & Johnson/Acquisition Dilution↓ [HIGH RISK]▼
The Firefly Bio and Sail Biomedicines deals will reduce 2026 adjusted EPS by $0.64 and 2027 EPS by $1.36, with full-year 2026 guidance cut 5.9% to $11.04, a significant earnings hit
- Visa/Shrinking Balance Sheet↓ [MEDIUM RISK]▼
Total assets declined 5.1% to $94,590M and total equity fell 7.2% to $35,178M, driven by aggressive share repurchases and dividends, reducing financial flexibility
- Coca-Cola/Financing Cash Flow Swing↓ [MEDIUM RISK]▼
Financing activities swung to a net use of $6,535M from a net source of $52M, reflecting higher debt repayments and dividends, which could pressure liquidity
- Microsoft/Consumer Business Decline↓ [MEDIUM RISK]▼
More Personal Computing revenue declined 1% for FY2026 and 4% in Q4, with Windows OEM and Xbox content down 7% and 10% respectively, showing structural headwinds
- Honeywell/Insider Selling Concentration↓ [MEDIUM RISK]▼
18 insider transactions reported with Pres/CEO Process Technologies selling $1.75M, a high volume of activity from a senior executive that may signal concerns about the division's outlook
- Procter & Gamble/Leadership Transition Risk↓ [LOW RISK]▼
CEO Shailesh Jejurikar becomes Chairman on August 1, 2026, while Executive Chairman Jon Moeller retires after 38 years, creating a period of leadership consolidation
- Coca-Cola/Insider Profit-Taking↓ [MEDIUM RISK]▼
Multiple option exercises and stock sales by Pietracci Bruno at $89.69, near recent highs, suggests insider belief that the stock is fully valued
Opportunities (9)
- Microsoft/Azure Growth Engine↓ (OPPORTUNITY)◆
Azure revenue surpassed $100B for the fiscal year with 30% Intelligent Cloud growth, and commercial RPO of $678B (+84% YoY) provides exceptional forward revenue visibility
- Coca-Cola/Cash Flow Rebound↓ (OPPORTUNITY)◆
Operating cash flow surged from a use of $1,391M to $7,543M YoY, a $8.9B swing, indicating working capital management improvements and potential for increased shareholder returns
- Visa/Litigation Risk Reduction↓ (OPPORTUNITY)◆
Litigation provisions dropped 59% to $253M from $615M, reducing a major overhang, while revenue grew 14.3% and operating income rose 11.3%
- Johnson & Johnson/Strategic Acquisitions↓ (OPPORTUNITY)◆
Firefly Bio and Sail Biomedicines deals target high-growth areas in biotech, with operational sales growth maintained at 6.5%-7.1%, suggesting long-term value despite near-term EPS dilution
- Microsoft/Operating Leverage↓ (OPPORTUNITY)◆
GAAP net income grew 31% YoY on 18% revenue growth, with R&D as a percent of revenue declining from 12% to 11%, showing improving efficiency
- Coca-Cola/Balance Sheet Improvement↓ (OPPORTUNITY)◆
Total equity rose 11.8% to $38,315M and long-term debt decreased 12.1% to $37,001M, strengthening the capital structure for future investments
- Procter & Gamble/Beauty Segment Strength↓ (OPPORTUNITY)◆
Beauty organic sales grew 4% in Q4, driven by Hair Care and Personal Care, outperforming the flat overall organic sales and indicating category leadership
- Microsoft/Search Advertising Growth↓ (OPPORTUNITY)◆
Search advertising revenue grew 10% YoY in Q4, bucking the trend in the declining More Personal Computing segment and showing AI-powered Bing gains
- Visa/Strong Profitability↓ (OPPORTUNITY)◆
Net income of $5,628M on $11,633M in revenue yields a 48.4% net margin, among the highest in the Dow 30, with operating income up 11.3%
Sector Themes (6)
- Tech Cloud Dominance vs. Consumer Weakness◆
Microsoft's cloud revenue grew 27% YoY to $59.3B, while its More Personal Computing segment declined 4%, highlighting the bifurcation within tech where enterprise cloud spending is robust but consumer hardware and gaming are under pressure
- Consumer Staples Margin Squeeze◆
P&G faces an 8% EPS headwind from costs and FX, while Coca-Cola's revenue growth of 6.7% outpaces but margins face similar pressures, indicating a sector-wide challenge from input cost inflation and currency headwinds
- Aggressive Capital Returns Shrinking Equity◆
Visa's equity fell 7.2% and assets declined 5.1% due to buybacks and dividends, while Coca-Cola's financing cash flow swung negative on debt repayments and dividends, showing a trend of returning capital to shareholders at the expense of balance sheet growth
- Insider Selling at Elevated Levels◆
Coca-Cola and Honeywell both saw significant insider sales, with Honeywell's divisional CEO selling $1.75M and Coca-Cola's executive selling $3.62M, suggesting management sees limited near-term upside in these mature industrials and consumer names
- M&A Driving Near-Term EPS Dilution◆
J&J's $0.64 and $1.36 EPS hits from acquisitions contrast with Microsoft's organic growth, showing that large-cap healthcare companies are using M&A for growth despite short-term earnings pain, while tech companies scale organically
- Guidance Conservatism Amid Uncertainty◆
P&G guided FY27 core EPS growth of in-line to 3% despite 3% sales growth, and J&J cut 2026 guidance by 5.9%, indicating a cautious outlook from consumer and healthcare companies facing macro headwinds
Watch List (8)
-
Q1 FY27 earnings call (late October 2026) to watch for Azure growth sustainability and whether commercial RPO of $678B converts to revenue as expected
-
Upcoming earnings calls to assess whether Firefly Bio and Sail Biomedicines milestones are achieved, which could trigger the $1.36 EPS reduction in 2027
-
FY27 guidance execution, particularly whether the $0.56 per share headwind from costs and FX materializes and if organic sales can return to growth
-
Q3 2026 results to see if operating cash flow strength continues and if long-term debt reduction pace accelerates, which could lead to dividend increases
- 👁
Q4 FY2026 results to monitor if litigation provisions remain low and if the declining equity base from buybacks impacts financial flexibility
-
Further insider transactions from divisional CEOs, particularly if more senior executives sell, which could signal broader concerns about the company's outlook
-
August 1, 2026 leadership transition as Shailesh Jejurikar becomes Chairman, to watch for any strategic shifts or organizational changes
-
Future insider filings from senior executives, as the CAO's sale under a 10b5-1 plan may precede further insider activity
Filing Analyses
(11)
29-07-2026
Visa Inc. reported net revenue of $11,633M for Q3 FY2026 (three months ended June 30, 2026), up 14.3% from $10,172M in Q3 FY2025. Net income increased 6.8% to $5,628M from $5,272M. However, total assets declined 5.1% to $94,590M from $99,627M, and total equity decreased 7.2% to $35,178M from $37,909M, driven by share repurchases and dividends.
- · Operating income for Q3 FY2026 was $6,877M, up 11.3% from $6,177M in Q3 FY2025.
- · Litigation provision for Q3 FY2026 was $253M, down from $615M in Q3 FY2025.
- · Cash and cash equivalents decreased to $12,359M as of June 30, 2026 from $17,164M as of September 30, 2025.
- · Total debt (current maturities + long-term) increased to $23,858M as of June 30, 2026 from $25,171M as of September 30, 2025.
- · Diluted EPS for Class A common stock was $2.97 for Q3 FY2026 vs $2.69 for Q3 FY2025.
- · Share repurchases of class A common stock totaled $16,537M for the nine months ended June 30, 2026.
- · Cash dividends declared and paid were $0.67 per class A common stock in Q3 FY2026, up from $0.59 in Q3 FY2025.
29-07-2026
Procter & Gamble reported fiscal year 2026 net sales of $87.0B, up 3% YoY, and diluted EPS of $6.62, up 2% YoY. However, Q4 FY26 showed a 15% decline in diluted EPS to $1.26 and a 3% decline in core EPS to $1.43, with organic sales flat. The company guided FY27 core EPS growth of in-line to 3%, but faces a $0.56 per share headwind from higher costs and unfavorable FX, representing an 8% drag on core EPS growth.
- · Beauty segment organic sales increased 4% in Q4, driven by Hair Care and Personal Care, but Skin Care was flat due to volume decline in Greater China.
- · Grooming segment organic sales were flat in Q4, as innovation pricing was offset by volume decline in IMEA and unfavorable product mix.
- · Health Care segment organic sales decreased 1% in Q4, with Oral Care down mid-single digits but Personal Health Care up mid-single digits.
- · Fabric and Home Care segment organic sales were flat in Q4; Fabric Care up low single digits, Home Care down low single digits.
- · Baby, Feminine and Family Care segment organic sales decreased 2% in Q4; Baby Care up low single digits, Feminine Care down low single digits, Family Care down mid-single digits.
- · Q4 reported gross margin decreased 60 bps; core gross margin unchanged as 160 bps productivity savings were offset by 120 bps unfavorable product mix and 70 bps product/package reinvestments.
- · Q4 reported SG&A as a % of sales increased 160 bps; core SG&A increased 130 bps due to 410 bps of reinvestments (mostly marketing) partially offset by 300 bps productivity savings.
- · Q4 reported operating margin decreased 220 bps; core operating margin decreased 130 bps.
- · FY27 guidance includes a headwind of 30-50 bps from brand, product form and go-to-market discontinuations.
- · FY27 core EPS guidance range is $6.89 to $7.11, with a mid-point of $7.00 (1.5% growth).
- · FY27 GAAP EPS includes expected non-core restructuring charges of $0.13 to $0.17 per share.
- · FY27 adjusted free cash flow productivity expected at 85% to 90%, down from 100% in FY26.
- · FY27 capital spending estimated at 4.5% to 5.5% of net sales.
- · The company expects to pay ~$10B in dividends and repurchase ~$5B in shares in FY27.
- · The portfolio and productivity plan announced in June 2025 expects non-core restructuring costs of $1 to $1.6 billion before-tax over two years; over half incurred in FY26, remainder in FY27.
29-07-2026
Procter & Gamble announced that Shailesh Jejurikar, currently President and CEO, will also become Chairman of the Board effective August 1, 2026, succeeding Jon Moeller, who will retire as Executive Chairman on July 31, 2026 and leave the company on August 14, 2026. Moeller served 38 years at P&G, including roles as Executive Chairman, CEO, COO, and CFO. The leadership transition is orderly and pre-planned, with no financial results or performance metrics disclosed.
- · Shailesh Jejurikar joined P&G in 1989 and has been on the global leadership team since 2014.
- · Jejurikar has led global Fabric Care and Home Care businesses across North America, Europe, Asia, and Latin America.
- · Jon Moeller's retirement from the Board is effective July 31, 2026, and from P&G effective August 14, 2026.
- · P&G operates in approximately 70 countries worldwide.
29-07-2026
Pietracci Bruno sold 40,334 Common Stock, $.25 Par Value at $89.69 (~$3.62M). 6 transactions reported in total. Pietracci Bruno holds 40,334 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Pietracci Bruno exercised/converted 35,393 Common Stock, $.25 Par Value at $59.49 (~$2.11M)
- · Pietracci Bruno sold 35,393 Common Stock, $.25 Par Value at $89.60 (~$3.17M)
- · Pietracci Bruno exercised/converted 40,334 Common Stock, $.25 Par Value at $50.44 (~$2.03M)
- · Pietracci Bruno sold 40,334 Common Stock, $.25 Par Value at $89.69 (~$3.62M)
- · Pietracci Bruno exercised/converted 35,393 Employee Stock Option (Right to Buy)
- · Pietracci Bruno exercised/converted 40,334 Employee Stock Option (Right to Buy)
29-07-2026
Coca-Cola reported strong financial results for Q2 and H1 2026, with net operating revenues increasing 6.7% to $13,380M in Q2 and 9.2% to $25,852M in H1. Net income attributable to shareowners rose 16.1% to $4,425M in Q2 and 16.9% to $8,349M in H1. However, operating cash flow surged to $7,543M from a use of $1,391M in the prior year period, while financing activities swung to a net use of $6,535M from a net source of $52M, reflecting higher dividend payments and debt repayments.
- · Total assets increased to $107,922M as of July 3, 2026 from $104,816M at December 31, 2025.
- · Total equity rose to $38,315M from $34,275M over the same period.
- · Long-term debt decreased to $37,001M from $42,119M, while current maturities of long-term debt increased to $6,494M from $1,822M.
- · Net foreign currency translation adjustments contributed $399M to OCI in Q2 and $357M in H1 2026.
- · The company repurchased $663M of treasury stock in H1 2026, up from $472M in H1 2025.
- · Interest expense decreased 17.1% in Q2 and 10.6% in H1 year-over-year.
29-07-2026
Microsoft reported strong Q4 FY26 results with revenue of $90.0B (+18% YoY), operating income of $40.6B (+18%), and GAAP net income of $35.8B (+31% YoY). Microsoft Cloud revenue reached $59.3B (+27% YoY), and Azure revenue surpassed $100B for the fiscal year. However, the More Personal Computing segment declined 4% YoY, with Windows OEM and Devices revenue down 7% and Xbox content and services revenue down 10%, partially offset by search advertising revenue growth of 10%.
- · Q4 FY26 GAAP diluted EPS was $4.81, up 32% YoY; non-GAAP diluted EPS was $4.74, up 23% YoY.
- · Commercial remaining performance obligation grew 84% YoY to $678 billion.
- · Microsoft 365 Commercial cloud revenue increased 14% YoY (16% adjusted for prior year revenue recognition).
- · Microsoft 365 Consumer cloud revenue increased 24% YoY (22% constant currency).
- · LinkedIn revenue increased 12% YoY (10% constant currency).
- · Dynamics 365 revenue increased 13% YoY (12% constant currency).
- · Azure and other cloud services revenue increased 43% YoY.
- · Search advertising revenue (ex-TAC) increased 10% YoY (9% constant currency).
- · Microsoft returned $10.2 billion to shareholders in Q4 via dividends and share repurchases.
- · FY26 total revenue was $331.8 billion (+18% YoY), operating income $155.2 billion (+21% YoY), GAAP net income $133.7 billion (+31% YoY).
- · FY26 GAAP diluted EPS was $17.95 (+32% YoY); non-GAAP diluted EPS was $17.28 (+22% YoY).
- · Q4 results included a $3.2 billion gain from investment in Anthropic and lower-than-expected Voluntary Retirement Program expenses, partially offset by Xbox severance and impairment charges.
- · The net impact from OpenAI investments added $480 million to GAAP net income in Q4 and $4,963 million for FY26.
29-07-2026
Microsoft reported strong FY2026 results with revenue of $331,839M, up 18% YoY, driven by 30% growth in Intelligent Cloud revenue to $137,791M. Net income surged 31% to $133,749M and diluted EPS rose 32% to $17.95. However, the More Personal Computing segment saw a 1% revenue decline to $54,052M, and cost of revenue for Intelligent Cloud grew 44%, outpacing revenue growth.
- · Intelligent Cloud cost of revenue grew 44% YoY, significantly outpacing its 30% revenue growth, indicating margin pressure.
- · More Personal Computing revenue declined 1% YoY to $54,052M, while operating income grew only 2%.
- · Research and development as a percent of revenue decreased from 12% to 11% YoY.
- · Sales and marketing as a percent of revenue decreased from 9% to 8% YoY.
- · General and administrative as a percent of revenue decreased from 3% to 2% YoY.
29-07-2026
Pres/CEO Process Technologies West Kenneth J sold 7,161 Common Stock at $243.77 (~$1.75M). 18 transactions reported in total. West Kenneth J holds 2,132 shares after the transaction.
- · Pres/CEO Process Technologies West Kenneth J exercised/converted 1,531 Common Stock at $193.82 (~$297K)
- · Pres/CEO Process Technologies West Kenneth J sold 1,531 Common Stock at $243.77 (~$373K)
- · Pres/CEO Process Technologies West Kenneth J exercised/converted 2,319 Common Stock at $181.39 (~$421K)
- · Pres/CEO Process Technologies West Kenneth J sold 2,319 Common Stock at $243.77 (~$565K)
- · Pres/CEO Process Technologies West Kenneth J exercised/converted 1,731 Common Stock at $185.78 (~$322K)
- · Pres/CEO Process Technologies West Kenneth J sold 1,731 Common Stock at $243.77 (~$422K)
- · Pres/CEO Process Technologies West Kenneth J exercised/converted 2,667 Common Stock at $189.01 (~$504K)
- · Pres/CEO Process Technologies West Kenneth J sold 2,667 Common Stock at $243.77 (~$650K)
29-07-2026
Johnson & Johnson announced the completion of its acquisition of Firefly Bio, Inc. and a strategic collaboration with Sail Biomedicines. The combined transactions are expected to reduce 2026 adjusted EPS by approximately $0.64 and 2027 adjusted EPS by approximately $1.36. As a result, J&J lowered its full-year 2026 adjusted EPS guidance midpoint from $11.68 to $11.04, a decline of 5.9% versus prior year, while maintaining its operational sales growth guidance of 6.5%-7.1%.
- · The company maintained its operational sales growth guidance of 6.5%-7.1% and reported sales growth of 7.0%-7.6%.
- · Currency impact on EPS is estimated at $0.10 (0.9%), unchanged from prior guidance.
- · The 2027 EPS reduction of $1.36 assumes Sail's achievement of certain development milestones and exercise of J&J's option.
- · The Firefly acquisition was completed on July 29, 2026; the Sail collaboration involves strategic agreements.
29-07-2026
VP, Chief Accounting Officer Saraci Marsida sold 449 Class C Capital Stock at $333.20 (~$150K). Saraci Marsida holds 27,386 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · VP, Chief Accounting Officer Saraci Marsida sold 449 Class C Capital Stock at $333.20 (~$150K)
29-07-2026
Procter & Gamble reported its fourth quarter and fiscal year 2026 results on July 29, 2026, and hosted a conference call. The company furnished informational slides referenced in the call via this 8-K filing. The filing does not include specific financial figures, so no period-over-period comparisons or balanced performance metrics are available.
- · The press release and conference call covered Q4 and full fiscal year 2026 results.
- · Informational slides (Exhibit 99.1) were furnished and posted on the company's website.
- · The filing is under Regulation FD (Item 7.01) and includes an exhibit index.
Get daily alerts with 12 investment signals, 9 risk alerts, 9 opportunities and full AI analysis of all 11 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Dow Jones 30 Stocks SEC Filings
🇺🇸 More from United States
View all →July 30, 2026
US Pre-Market SEC Filings Roundup — July 30, 2026
US Pre-Market SEC Filings Roundup
July 30, 2026
USA Corporate Events Calendar — July 30, 2026
USA Corporate Events Calendar
July 30, 2026
USA Earnings Calls Schedule — July 30, 2026
USA Earnings Calls Schedule
July 30, 2026
USA Insider Trading Pulse — July 30, 2026
USA Insider Trading Pulse